BSE filing, NSE: VIYASH. Summary written from the filing by ALFA Finder's alert engine.
Viyash Scientific Ltd: key numbers
- Share price
- ₹258.90
- Market cap
- ₹11,443 Cr
- Revenue (annual)
- ₹3,420 Cr
- Net profit (annual)
- ₹177.3 Cr
- P/E (TTM)
- 66.9×Sector 43.8×
- Promoter holding
- 49.24%-12.07% QoQ
- FII holding
- 2.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Viyash Scientific Ltd
All →Viyash Scientific Q2 FY27 Results: Net Profit ₹84.7 Cr, Up 16.2% YoY
Viyash Scientific Ltd filed unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Standalone revenue from operations was INR 3,906.50 million for the quarter.
- Key figure
- Net profit ₹84.7 Cr · +16.2% YoY
Viyash Scientific Employee Stock Options
Viyash Scientific allotted 228,408 shares under two employee stock option schemes. Paid-up capital rose to 44,19,91,958 shares of Rs.2 each.
Viyash Scientific Board Meeting Date
Viyash Scientific will hold a board meeting on 13 November 2026 to consider unaudited quarterly and half-yearly results. The trading window remains closed until 15 November 2026.
Viyash Scientific Merger & Restructuring Worth ₹3.8 Cr
Viyash's step-down subsidiary Alivira Vietnam was incorporated on 30 October 2026, with investment up to USD 400,000. It will distribute animal health products and APIs in Vietnam.
- Value
- ₹3.80 Cr
Viyash Scientific Management Change
Viyash Scientific Limited has appointed Dr. Mallikharjuna Rao Nagineni as Senior Vice President, Human Resources, succeeding the retiring Mr. Prasad Lad.
Viyash Scientific Capital Structure Change
White Oak Capital Management Consultants LLP disclosed the sale of 8,747,392 equity shares of Viyash Scientific Ltd, reducing its stake in the open market.
Other results update announcements
All →Innova Captab Results Update
Innova Captab reported Q2 FY27 revenue of Rs.496.3 Crore, up 30.5%, with PAT up 43%. The press release summarises unaudited quarterly and half-year results.
Duroply Industries Results Update
Duroply reported unaudited Q2 FY27 results with profit up sharply year-on-year. Revenue and EBIT also grew, alongside a new Duro HDMMR MDF launch.
CPS Shapers Results Update
CPS Shapers reported H1 FY27 revenue of ₹13.82 Crore, up 17.8%, with EBITDA loss narrowing to ₹1.02 Crore. The press release accompanies its unaudited half-year results.
Proventus Agrocom Results Update
Proventus Agrocom's H1FY27 shareholders' letter reports consolidated revenue of ₹634 Cr, up 63% YoY. EBITDA rose 80% to ₹16.6 Cr and PAT grew 77% to ₹11.8 Cr.
Methodhub Software Results Update
MethodHub Software reported H1 FY2026-27 consolidated revenue up 133.5% to ₹1,866.78 million and PAT up 88%. Subsidiary Nemera also won a ~₹161 crore Thailand telecom contract.
Asarfi Hospital Results Update
Asarfi Hospital posted record Q2 FY27 revenue of Rs.5,287 lakhs, up 18%, with PAT up 43%. The press release accompanies unaudited Q2 results.